Global Immunological Agents Production, Demand and Key Producers, 2022-2028
This report studies the global Immunological Agents demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunological Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunological Agents that contribute to its increasing demand across many markets.
The global Immunological Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Immunological Agents total market, 2017-2028, (USD Million)
Global Immunological Agents total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Immunological Agents total market, key domestic companies and share, (USD Million)
Global Immunological Agents revenue by player and market share 2017-2022, (USD Million)
Global Immunological Agents total market by Type, CAGR, 2017-2028, (USD Million)
Global Immunological Agents total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Immunological Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immunological Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Immunological Agents Market, By Region:
1. How big is the global Immunological Agents market?
2. What is the demand of the global Immunological Agents market?
3. What is the year over year growth of the global Immunological Agents market?
4. What is the total value of the global Immunological Agents market?
5. Who are the major players in the global Immunological Agents market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Immunological Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunological Agents that contribute to its increasing demand across many markets.
The global Immunological Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Immunological Agents total market, 2017-2028, (USD Million)
Global Immunological Agents total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Immunological Agents total market, key domestic companies and share, (USD Million)
Global Immunological Agents revenue by player and market share 2017-2022, (USD Million)
Global Immunological Agents total market by Type, CAGR, 2017-2028, (USD Million)
Global Immunological Agents total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Immunological Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immunological Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Immunological Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antirheumatic Drugs (DMARDs)
- Immune Globulins
- Immunomodulatory Agents
- Immunosuppressive Agents
- Monoclonal Antibodies
- Other
- Hospital
- Clinics
- Others
- Abbott
- Organon
- Pfizer
- Sandoz
- Amneal Pharmaceuticals
- Apotex
- Teva Pharmaceuticals
- Biocon
- Bristol Myers Squibb
- Merck
- CSL Behring
- Sanofi
- Leading Pharma
- Accord Healthcare Inc
- Amgen
- Nabi Biopharmaceuticals
- Ascend Laboratories
- Camber Pharmaceuticals Inc
- Grifols USA
- JOM Pharmaceuticals
1. How big is the global Immunological Agents market?
2. What is the demand of the global Immunological Agents market?
3. What is the year over year growth of the global Immunological Agents market?
4. What is the total value of the global Immunological Agents market?
5. Who are the major players in the global Immunological Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immunological Agents Introduction
1.2 World Immunological Agents Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Immunological Agents Total Market by Region
1.3.1 World Immunological Agents Market Size by Region (2017-2028)
1.3.2 United States Immunological Agents Market Size (2017-2028)
1.3.3 China Immunological Agents Market Size (2017-2028)
1.3.4 Europe Immunological Agents Market Size (2017-2028)
1.3.5 Japan Immunological Agents Market Size (2017-2028)
1.3.6 South Korea Immunological Agents Market Size (2017-2028)
1.3.7 ASEAN Immunological Agents Market Size (2017-2028)
1.3.8 India Immunological Agents Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunological Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immunological Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD IMMUNOLOGICAL AGENTS COMPANIES COMPETITIVE ANALYSIS
2.1 World Immunological Agents Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Immunological Agents Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Immunological Agents in 2021
2.2.3 Global Concentration Ratios (CR8) for Immunological Agents in 2021
2.3 Immunological Agents Company Evaluation Quadrant
2.4 Immunological Agents Market: Overall Company Footprint Analysis
2.4.1 Immunological Agents Market: Region Footprint
2.4.2 Immunological Agents Market: Company Product Type Footprint
2.4.3 Immunological Agents Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Immunological Agents Market Comparison
3.1.1 United States VS China: Immunological Agents Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Immunological Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Immunological Agents Major Players and Market Share, 2017-2022
3.2.1 Major Players of Immunological Agents in United States, Headquarters (States, Country)
3.2.2 United States Immunological Agents Revenue by Domestic Player, (2017-2022)
3.3 China Immunological Agents Major Players and Market Share, 2017-2022
3.3.1 Major Players of Immunological Agents in China, Headquarters (Province, Country)
3.3.2 China Immunological Agents Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Immunological Agents Major Players and Market Share, 2017-2022
3.4.1 Major Players of Immunological Agents in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Immunological Agents Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Immunological Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Antirheumatic Drugs (DMARDs)
4.2.2 Immune Globulins
4.2.3 Immunomodulatory Agents
4.2.4 Immunosuppressive Agents
4.2.5 Monoclonal Antibodies
4.2.6 Other
4.3 Market Segment by Type
4.3.1 World Immunological Agents Market Size by Type (2017-2022)
4.3.2 World Immunological Agents Market Size by Type (2023-2028)
4.3.3 World Immunological Agents Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Immunological Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital
5.2.2 Clinics
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Immunological Agents Market Size by Application (2017-2022)
5.3.2 World Immunological Agents Market Size by Application (2023-2028)
5.3.3 World Immunological Agents Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Immunological Agents Product and Services
6.1.4 Abbott Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Organon
6.2.1 Organon Details
6.2.2 Organon Major Business
6.2.3 Organon Immunological Agents Product and Services
6.2.4 Organon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Organon Recent Developments/Updates
6.2.6 Organon Competitive Strengths & Weaknesses
6.3 Pfizer
6.3.1 Pfizer Details
6.3.2 Pfizer Major Business
6.3.3 Pfizer Immunological Agents Product and Services
6.3.4 Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Pfizer Recent Developments/Updates
6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Sandoz
6.4.1 Sandoz Details
6.4.2 Sandoz Major Business
6.4.3 Sandoz Immunological Agents Product and Services
6.4.4 Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Sandoz Recent Developments/Updates
6.4.6 Sandoz Competitive Strengths & Weaknesses
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Details
6.5.2 Amneal Pharmaceuticals Major Business
6.5.3 Amneal Pharmaceuticals Immunological Agents Product and Services
6.5.4 Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
6.6 Apotex
6.6.1 Apotex Details
6.6.2 Apotex Major Business
6.6.3 Apotex Immunological Agents Product and Services
6.6.4 Apotex Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Apotex Recent Developments/Updates
6.6.6 Apotex Competitive Strengths & Weaknesses
6.7 Teva Pharmaceuticals
6.7.1 Teva Pharmaceuticals Details
6.7.2 Teva Pharmaceuticals Major Business
6.7.3 Teva Pharmaceuticals Immunological Agents Product and Services
6.7.4 Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.7.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.8 Biocon
6.8.1 Biocon Details
6.8.2 Biocon Major Business
6.8.3 Biocon Immunological Agents Product and Services
6.8.4 Biocon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Biocon Recent Developments/Updates
6.8.6 Biocon Competitive Strengths & Weaknesses
6.9 Bristol Myers Squibb
6.9.1 Bristol Myers Squibb Details
6.9.2 Bristol Myers Squibb Major Business
6.9.3 Bristol Myers Squibb Immunological Agents Product and Services
6.9.4 Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Bristol Myers Squibb Recent Developments/Updates
6.9.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
6.10 Merck
6.10.1 Merck Details
6.10.2 Merck Major Business
6.10.3 Merck Immunological Agents Product and Services
6.10.4 Merck Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Merck Recent Developments/Updates
6.10.6 Merck Competitive Strengths & Weaknesses
6.11 CSL Behring
6.11.1 CSL Behring Details
6.11.2 CSL Behring Major Business
6.11.3 CSL Behring Immunological Agents Product and Services
6.11.4 CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 CSL Behring Recent Developments/Updates
6.11.6 CSL Behring Competitive Strengths & Weaknesses
6.12 Sanofi
6.12.1 Sanofi Details
6.12.2 Sanofi Major Business
6.12.3 Sanofi Immunological Agents Product and Services
6.12.4 Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Sanofi Recent Developments/Updates
6.12.6 Sanofi Competitive Strengths & Weaknesses
6.13 Leading Pharma
6.13.1 Leading Pharma Details
6.13.2 Leading Pharma Major Business
6.13.3 Leading Pharma Immunological Agents Product and Services
6.13.4 Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Leading Pharma Recent Developments/Updates
6.13.6 Leading Pharma Competitive Strengths & Weaknesses
6.14 Accord Healthcare Inc
6.14.1 Accord Healthcare Inc Details
6.14.2 Accord Healthcare Inc Major Business
6.14.3 Accord Healthcare Inc Immunological Agents Product and Services
6.14.4 Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Accord Healthcare Inc Recent Developments/Updates
6.14.6 Accord Healthcare Inc Competitive Strengths & Weaknesses
6.15 Amgen
6.15.1 Amgen Details
6.15.2 Amgen Major Business
6.15.3 Amgen Immunological Agents Product and Services
6.15.4 Amgen Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Amgen Recent Developments/Updates
6.15.6 Amgen Competitive Strengths & Weaknesses
6.16 Nabi Biopharmaceuticals
6.16.1 Nabi Biopharmaceuticals Details
6.16.2 Nabi Biopharmaceuticals Major Business
6.16.3 Nabi Biopharmaceuticals Immunological Agents Product and Services
6.16.4 Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Nabi Biopharmaceuticals Recent Developments/Updates
6.16.6 Nabi Biopharmaceuticals Competitive Strengths & Weaknesses
6.17 Ascend Laboratories
6.17.1 Ascend Laboratories Details
6.17.2 Ascend Laboratories Major Business
6.17.3 Ascend Laboratories Immunological Agents Product and Services
6.17.4 Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Ascend Laboratories Recent Developments/Updates
6.17.6 Ascend Laboratories Competitive Strengths & Weaknesses
6.18 Camber Pharmaceuticals Inc
6.18.1 Camber Pharmaceuticals Inc Details
6.18.2 Camber Pharmaceuticals Inc Major Business
6.18.3 Camber Pharmaceuticals Inc Immunological Agents Product and Services
6.18.4 Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Camber Pharmaceuticals Inc Recent Developments/Updates
6.18.6 Camber Pharmaceuticals Inc Competitive Strengths & Weaknesses
6.19 Grifols USA
6.19.1 Grifols USA Details
6.19.2 Grifols USA Major Business
6.19.3 Grifols USA Immunological Agents Product and Services
6.19.4 Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Grifols USA Recent Developments/Updates
6.19.6 Grifols USA Competitive Strengths & Weaknesses
6.20 JOM Pharmaceuticals
6.20.1 JOM Pharmaceuticals Details
6.20.2 JOM Pharmaceuticals Major Business
6.20.3 JOM Pharmaceuticals Immunological Agents Product and Services
6.20.4 JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 JOM Pharmaceuticals Recent Developments/Updates
6.20.6 JOM Pharmaceuticals Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Immunological Agents and Key Manufacturers
7.2 Immunological Agents Manufacturing Costs
7.3 Immunological Agents Production Process
7.4 Immunological Agents Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Immunological Agents Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Immunological Agents Typical Distributors
8.3 Immunological Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Immunological Agents Introduction
1.2 World Immunological Agents Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Immunological Agents Total Market by Region
1.3.1 World Immunological Agents Market Size by Region (2017-2028)
1.3.2 United States Immunological Agents Market Size (2017-2028)
1.3.3 China Immunological Agents Market Size (2017-2028)
1.3.4 Europe Immunological Agents Market Size (2017-2028)
1.3.5 Japan Immunological Agents Market Size (2017-2028)
1.3.6 South Korea Immunological Agents Market Size (2017-2028)
1.3.7 ASEAN Immunological Agents Market Size (2017-2028)
1.3.8 India Immunological Agents Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunological Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immunological Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD IMMUNOLOGICAL AGENTS COMPANIES COMPETITIVE ANALYSIS
2.1 World Immunological Agents Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Immunological Agents Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Immunological Agents in 2021
2.2.3 Global Concentration Ratios (CR8) for Immunological Agents in 2021
2.3 Immunological Agents Company Evaluation Quadrant
2.4 Immunological Agents Market: Overall Company Footprint Analysis
2.4.1 Immunological Agents Market: Region Footprint
2.4.2 Immunological Agents Market: Company Product Type Footprint
2.4.3 Immunological Agents Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Immunological Agents Market Comparison
3.1.1 United States VS China: Immunological Agents Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Immunological Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Immunological Agents Major Players and Market Share, 2017-2022
3.2.1 Major Players of Immunological Agents in United States, Headquarters (States, Country)
3.2.2 United States Immunological Agents Revenue by Domestic Player, (2017-2022)
3.3 China Immunological Agents Major Players and Market Share, 2017-2022
3.3.1 Major Players of Immunological Agents in China, Headquarters (Province, Country)
3.3.2 China Immunological Agents Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Immunological Agents Major Players and Market Share, 2017-2022
3.4.1 Major Players of Immunological Agents in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Immunological Agents Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Immunological Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Antirheumatic Drugs (DMARDs)
4.2.2 Immune Globulins
4.2.3 Immunomodulatory Agents
4.2.4 Immunosuppressive Agents
4.2.5 Monoclonal Antibodies
4.2.6 Other
4.3 Market Segment by Type
4.3.1 World Immunological Agents Market Size by Type (2017-2022)
4.3.2 World Immunological Agents Market Size by Type (2023-2028)
4.3.3 World Immunological Agents Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Immunological Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital
5.2.2 Clinics
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Immunological Agents Market Size by Application (2017-2022)
5.3.2 World Immunological Agents Market Size by Application (2023-2028)
5.3.3 World Immunological Agents Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Immunological Agents Product and Services
6.1.4 Abbott Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Organon
6.2.1 Organon Details
6.2.2 Organon Major Business
6.2.3 Organon Immunological Agents Product and Services
6.2.4 Organon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Organon Recent Developments/Updates
6.2.6 Organon Competitive Strengths & Weaknesses
6.3 Pfizer
6.3.1 Pfizer Details
6.3.2 Pfizer Major Business
6.3.3 Pfizer Immunological Agents Product and Services
6.3.4 Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Pfizer Recent Developments/Updates
6.3.6 Pfizer Competitive Strengths & Weaknesses
6.4 Sandoz
6.4.1 Sandoz Details
6.4.2 Sandoz Major Business
6.4.3 Sandoz Immunological Agents Product and Services
6.4.4 Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Sandoz Recent Developments/Updates
6.4.6 Sandoz Competitive Strengths & Weaknesses
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Details
6.5.2 Amneal Pharmaceuticals Major Business
6.5.3 Amneal Pharmaceuticals Immunological Agents Product and Services
6.5.4 Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
6.6 Apotex
6.6.1 Apotex Details
6.6.2 Apotex Major Business
6.6.3 Apotex Immunological Agents Product and Services
6.6.4 Apotex Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Apotex Recent Developments/Updates
6.6.6 Apotex Competitive Strengths & Weaknesses
6.7 Teva Pharmaceuticals
6.7.1 Teva Pharmaceuticals Details
6.7.2 Teva Pharmaceuticals Major Business
6.7.3 Teva Pharmaceuticals Immunological Agents Product and Services
6.7.4 Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.7.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.8 Biocon
6.8.1 Biocon Details
6.8.2 Biocon Major Business
6.8.3 Biocon Immunological Agents Product and Services
6.8.4 Biocon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Biocon Recent Developments/Updates
6.8.6 Biocon Competitive Strengths & Weaknesses
6.9 Bristol Myers Squibb
6.9.1 Bristol Myers Squibb Details
6.9.2 Bristol Myers Squibb Major Business
6.9.3 Bristol Myers Squibb Immunological Agents Product and Services
6.9.4 Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Bristol Myers Squibb Recent Developments/Updates
6.9.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
6.10 Merck
6.10.1 Merck Details
6.10.2 Merck Major Business
6.10.3 Merck Immunological Agents Product and Services
6.10.4 Merck Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Merck Recent Developments/Updates
6.10.6 Merck Competitive Strengths & Weaknesses
6.11 CSL Behring
6.11.1 CSL Behring Details
6.11.2 CSL Behring Major Business
6.11.3 CSL Behring Immunological Agents Product and Services
6.11.4 CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 CSL Behring Recent Developments/Updates
6.11.6 CSL Behring Competitive Strengths & Weaknesses
6.12 Sanofi
6.12.1 Sanofi Details
6.12.2 Sanofi Major Business
6.12.3 Sanofi Immunological Agents Product and Services
6.12.4 Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Sanofi Recent Developments/Updates
6.12.6 Sanofi Competitive Strengths & Weaknesses
6.13 Leading Pharma
6.13.1 Leading Pharma Details
6.13.2 Leading Pharma Major Business
6.13.3 Leading Pharma Immunological Agents Product and Services
6.13.4 Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Leading Pharma Recent Developments/Updates
6.13.6 Leading Pharma Competitive Strengths & Weaknesses
6.14 Accord Healthcare Inc
6.14.1 Accord Healthcare Inc Details
6.14.2 Accord Healthcare Inc Major Business
6.14.3 Accord Healthcare Inc Immunological Agents Product and Services
6.14.4 Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Accord Healthcare Inc Recent Developments/Updates
6.14.6 Accord Healthcare Inc Competitive Strengths & Weaknesses
6.15 Amgen
6.15.1 Amgen Details
6.15.2 Amgen Major Business
6.15.3 Amgen Immunological Agents Product and Services
6.15.4 Amgen Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Amgen Recent Developments/Updates
6.15.6 Amgen Competitive Strengths & Weaknesses
6.16 Nabi Biopharmaceuticals
6.16.1 Nabi Biopharmaceuticals Details
6.16.2 Nabi Biopharmaceuticals Major Business
6.16.3 Nabi Biopharmaceuticals Immunological Agents Product and Services
6.16.4 Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Nabi Biopharmaceuticals Recent Developments/Updates
6.16.6 Nabi Biopharmaceuticals Competitive Strengths & Weaknesses
6.17 Ascend Laboratories
6.17.1 Ascend Laboratories Details
6.17.2 Ascend Laboratories Major Business
6.17.3 Ascend Laboratories Immunological Agents Product and Services
6.17.4 Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Ascend Laboratories Recent Developments/Updates
6.17.6 Ascend Laboratories Competitive Strengths & Weaknesses
6.18 Camber Pharmaceuticals Inc
6.18.1 Camber Pharmaceuticals Inc Details
6.18.2 Camber Pharmaceuticals Inc Major Business
6.18.3 Camber Pharmaceuticals Inc Immunological Agents Product and Services
6.18.4 Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Camber Pharmaceuticals Inc Recent Developments/Updates
6.18.6 Camber Pharmaceuticals Inc Competitive Strengths & Weaknesses
6.19 Grifols USA
6.19.1 Grifols USA Details
6.19.2 Grifols USA Major Business
6.19.3 Grifols USA Immunological Agents Product and Services
6.19.4 Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Grifols USA Recent Developments/Updates
6.19.6 Grifols USA Competitive Strengths & Weaknesses
6.20 JOM Pharmaceuticals
6.20.1 JOM Pharmaceuticals Details
6.20.2 JOM Pharmaceuticals Major Business
6.20.3 JOM Pharmaceuticals Immunological Agents Product and Services
6.20.4 JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 JOM Pharmaceuticals Recent Developments/Updates
6.20.6 JOM Pharmaceuticals Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Immunological Agents and Key Manufacturers
7.2 Immunological Agents Manufacturing Costs
7.3 Immunological Agents Production Process
7.4 Immunological Agents Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Immunological Agents Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Immunological Agents Typical Distributors
8.3 Immunological Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Immunological Agents Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Immunological Agents Market Size by Region (2017-2022) & (USD Million)
Table 3. World Immunological Agents Market Size by Region (2023-2028) & (USD Million)
Table 4. World Immunological Agents Market Size Market Share by Region (2017-2022)
Table 5. World Immunological Agents Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Immunological Agents Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Immunological Agents Players in 2021
Table 9. World Immunological Agents Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Immunological Agents Company Evaluation Quadrant
Table 11. Head Office of Key Immunological Agents Player
Table 12. Immunological Agents Market: Company Product Type Footprint
Table 13. Immunological Agents Market: Company Product Application Footprint
Table 14. Immunological Agents Mergers & Acquisitions Activity
Table 15. United States VS China Immunological Agents Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Immunological Agents in United States, Headquarters (States, Country)
Table 17. United States Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Immunological Agents in China, Company Headquarters (Province, Country)
Table 20. China Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Immunological Agents in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Immunological Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Immunological Agents Revenue by Type (2017-2022) & (USD Million)
Table 27. World Immunological Agents Revenue by Type (2023-2028) & (USD Million)
Table 28. World Immunological Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Immunological Agents Revenue by Application (2017-2022) & (USD Million)
Table 30. World Immunological Agents Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Immunological Agents Product and Services
Table 34. Abbott Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Organon Basic Information, Manufacturing Base and Competitors
Table 38. Organon Major Business
Table 39. Organon Immunological Agents Product and Services
Table 40. Organon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Organon Recent Developments/Updates
Table 42. Organon Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Immunological Agents Product and Services
Table 46. Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Sandoz Basic Information, Manufacturing Base and Competitors
Table 50. Sandoz Major Business
Table 51. Sandoz Immunological Agents Product and Services
Table 52. Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Sandoz Recent Developments/Updates
Table 54. Sandoz Competitive Strengths & Weaknesses
Table 55. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Amneal Pharmaceuticals Major Business
Table 57. Amneal Pharmaceuticals Immunological Agents Product and Services
Table 58. Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Amneal Pharmaceuticals Recent Developments/Updates
Table 60. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 61. Apotex Basic Information, Manufacturing Base and Competitors
Table 62. Apotex Major Business
Table 63. Apotex Immunological Agents Product and Services
Table 64. Apotex Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Apotex Recent Developments/Updates
Table 66. Apotex Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Immunological Agents Product and Services
Table 70. Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Biocon Basic Information, Manufacturing Base and Competitors
Table 74. Biocon Major Business
Table 75. Biocon Immunological Agents Product and Services
Table 76. Biocon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Biocon Recent Developments/Updates
Table 78. Biocon Competitive Strengths & Weaknesses
Table 79. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 80. Bristol Myers Squibb Major Business
Table 81. Bristol Myers Squibb Immunological Agents Product and Services
Table 82. Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Bristol Myers Squibb Recent Developments/Updates
Table 84. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Immunological Agents Product and Services
Table 88. Merck Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 92. CSL Behring Major Business
Table 93. CSL Behring Immunological Agents Product and Services
Table 94. CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. CSL Behring Recent Developments/Updates
Table 96. CSL Behring Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Immunological Agents Product and Services
Table 100. Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Leading Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Leading Pharma Major Business
Table 105. Leading Pharma Immunological Agents Product and Services
Table 106. Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Leading Pharma Recent Developments/Updates
Table 108. Leading Pharma Competitive Strengths & Weaknesses
Table 109. Accord Healthcare Inc Basic Information, Manufacturing Base and Competitors
Table 110. Accord Healthcare Inc Major Business
Table 111. Accord Healthcare Inc Immunological Agents Product and Services
Table 112. Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Accord Healthcare Inc Recent Developments/Updates
Table 114. Accord Healthcare Inc Competitive Strengths & Weaknesses
Table 115. Amgen Basic Information, Manufacturing Base and Competitors
Table 116. Amgen Major Business
Table 117. Amgen Immunological Agents Product and Services
Table 118. Amgen Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Amgen Recent Developments/Updates
Table 120. Amgen Competitive Strengths & Weaknesses
Table 121. Nabi Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Nabi Biopharmaceuticals Major Business
Table 123. Nabi Biopharmaceuticals Immunological Agents Product and Services
Table 124. Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Nabi Biopharmaceuticals Recent Developments/Updates
Table 126. Nabi Biopharmaceuticals Competitive Strengths & Weaknesses
Table 127. Ascend Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Ascend Laboratories Major Business
Table 129. Ascend Laboratories Immunological Agents Product and Services
Table 130. Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Ascend Laboratories Recent Developments/Updates
Table 132. Ascend Laboratories Competitive Strengths & Weaknesses
Table 133. Camber Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 134. Camber Pharmaceuticals Inc Major Business
Table 135. Camber Pharmaceuticals Inc Immunological Agents Product and Services
Table 136. Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Camber Pharmaceuticals Inc Recent Developments/Updates
Table 138. Camber Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 139. Grifols USA Basic Information, Manufacturing Base and Competitors
Table 140. Grifols USA Major Business
Table 141. Grifols USA Immunological Agents Product and Services
Table 142. Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Grifols USA Recent Developments/Updates
Table 144. JOM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. JOM Pharmaceuticals Major Business
Table 146. JOM Pharmaceuticals Immunological Agents Product and Services
Table 147. JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Immunological Agents Raw Material
Table 149. Key Manufacturers of Immunological Agents Raw Materials
Table 150. Immunological Agents Typical Distributors
Table 151. Immunological Agents Typical Customers
Table 1. World Immunological Agents Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Immunological Agents Market Size by Region (2017-2022) & (USD Million)
Table 3. World Immunological Agents Market Size by Region (2023-2028) & (USD Million)
Table 4. World Immunological Agents Market Size Market Share by Region (2017-2022)
Table 5. World Immunological Agents Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Immunological Agents Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Immunological Agents Players in 2021
Table 9. World Immunological Agents Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Immunological Agents Company Evaluation Quadrant
Table 11. Head Office of Key Immunological Agents Player
Table 12. Immunological Agents Market: Company Product Type Footprint
Table 13. Immunological Agents Market: Company Product Application Footprint
Table 14. Immunological Agents Mergers & Acquisitions Activity
Table 15. United States VS China Immunological Agents Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Immunological Agents in United States, Headquarters (States, Country)
Table 17. United States Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Immunological Agents in China, Company Headquarters (Province, Country)
Table 20. China Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Immunological Agents in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Immunological Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Immunological Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Immunological Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Immunological Agents Revenue by Type (2017-2022) & (USD Million)
Table 27. World Immunological Agents Revenue by Type (2023-2028) & (USD Million)
Table 28. World Immunological Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Immunological Agents Revenue by Application (2017-2022) & (USD Million)
Table 30. World Immunological Agents Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Immunological Agents Product and Services
Table 34. Abbott Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Organon Basic Information, Manufacturing Base and Competitors
Table 38. Organon Major Business
Table 39. Organon Immunological Agents Product and Services
Table 40. Organon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Organon Recent Developments/Updates
Table 42. Organon Competitive Strengths & Weaknesses
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Immunological Agents Product and Services
Table 46. Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Pfizer Recent Developments/Updates
Table 48. Pfizer Competitive Strengths & Weaknesses
Table 49. Sandoz Basic Information, Manufacturing Base and Competitors
Table 50. Sandoz Major Business
Table 51. Sandoz Immunological Agents Product and Services
Table 52. Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Sandoz Recent Developments/Updates
Table 54. Sandoz Competitive Strengths & Weaknesses
Table 55. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Amneal Pharmaceuticals Major Business
Table 57. Amneal Pharmaceuticals Immunological Agents Product and Services
Table 58. Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Amneal Pharmaceuticals Recent Developments/Updates
Table 60. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 61. Apotex Basic Information, Manufacturing Base and Competitors
Table 62. Apotex Major Business
Table 63. Apotex Immunological Agents Product and Services
Table 64. Apotex Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Apotex Recent Developments/Updates
Table 66. Apotex Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Immunological Agents Product and Services
Table 70. Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Biocon Basic Information, Manufacturing Base and Competitors
Table 74. Biocon Major Business
Table 75. Biocon Immunological Agents Product and Services
Table 76. Biocon Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Biocon Recent Developments/Updates
Table 78. Biocon Competitive Strengths & Weaknesses
Table 79. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 80. Bristol Myers Squibb Major Business
Table 81. Bristol Myers Squibb Immunological Agents Product and Services
Table 82. Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Bristol Myers Squibb Recent Developments/Updates
Table 84. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Immunological Agents Product and Services
Table 88. Merck Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 92. CSL Behring Major Business
Table 93. CSL Behring Immunological Agents Product and Services
Table 94. CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. CSL Behring Recent Developments/Updates
Table 96. CSL Behring Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Immunological Agents Product and Services
Table 100. Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Leading Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Leading Pharma Major Business
Table 105. Leading Pharma Immunological Agents Product and Services
Table 106. Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Leading Pharma Recent Developments/Updates
Table 108. Leading Pharma Competitive Strengths & Weaknesses
Table 109. Accord Healthcare Inc Basic Information, Manufacturing Base and Competitors
Table 110. Accord Healthcare Inc Major Business
Table 111. Accord Healthcare Inc Immunological Agents Product and Services
Table 112. Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Accord Healthcare Inc Recent Developments/Updates
Table 114. Accord Healthcare Inc Competitive Strengths & Weaknesses
Table 115. Amgen Basic Information, Manufacturing Base and Competitors
Table 116. Amgen Major Business
Table 117. Amgen Immunological Agents Product and Services
Table 118. Amgen Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Amgen Recent Developments/Updates
Table 120. Amgen Competitive Strengths & Weaknesses
Table 121. Nabi Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Nabi Biopharmaceuticals Major Business
Table 123. Nabi Biopharmaceuticals Immunological Agents Product and Services
Table 124. Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Nabi Biopharmaceuticals Recent Developments/Updates
Table 126. Nabi Biopharmaceuticals Competitive Strengths & Weaknesses
Table 127. Ascend Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Ascend Laboratories Major Business
Table 129. Ascend Laboratories Immunological Agents Product and Services
Table 130. Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Ascend Laboratories Recent Developments/Updates
Table 132. Ascend Laboratories Competitive Strengths & Weaknesses
Table 133. Camber Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 134. Camber Pharmaceuticals Inc Major Business
Table 135. Camber Pharmaceuticals Inc Immunological Agents Product and Services
Table 136. Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Camber Pharmaceuticals Inc Recent Developments/Updates
Table 138. Camber Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 139. Grifols USA Basic Information, Manufacturing Base and Competitors
Table 140. Grifols USA Major Business
Table 141. Grifols USA Immunological Agents Product and Services
Table 142. Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Grifols USA Recent Developments/Updates
Table 144. JOM Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. JOM Pharmaceuticals Major Business
Table 146. JOM Pharmaceuticals Immunological Agents Product and Services
Table 147. JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 148. Immunological Agents Raw Material
Table 149. Key Manufacturers of Immunological Agents Raw Materials
Table 150. Immunological Agents Typical Distributors
Table 151. Immunological Agents Typical Customers
LIST OF FIGURES
Figure 1. Immunological Agents Picture
Figure 2. World Immunological Agents Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Immunological Agents Total Market Size (2017-2028) & (USD Million)
Figure 4. World Immunological Agents Market Size Market Share by Region (2017-2028)
Figure 5. United States Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 6. China Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 7. Europe Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 8. Japan Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 11. India Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 12. Immunological Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Immunological Agents by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Immunological Agents Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Immunological Agents Markets in 2021
Figure 17. United States VS China: Immunological Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Immunological Agents Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Immunological Agents Market Size Market Share by Type in 2021
Figure 20. Antirheumatic Drugs (DMARDs)
Figure 21. Immune Globulins
Figure 22. Immunomodulatory Agents
Figure 23. Immunosuppressive Agents
Figure 24. Monoclonal Antibodies
Figure 25. Other
Figure 26. World Immunological Agents Market Size Market Share by Type (2017-2028)
Figure 27. World Immunological Agents Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Immunological Agents Market Size Market Share by Application in 2021
Figure 29. Hospital
Figure 30. Clinics
Figure 31. Others
Figure 32. World Immunological Agents Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Immunological Agents in 2021
Figure 34. Manufacturing Process Analysis of Immunological Agents
Figure 35. Immunological Agents Industrial Chain
Figure 36. Distribution Channel Breakdown for Immunological Agents Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Immunological Agents Picture
Figure 2. World Immunological Agents Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Immunological Agents Total Market Size (2017-2028) & (USD Million)
Figure 4. World Immunological Agents Market Size Market Share by Region (2017-2028)
Figure 5. United States Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 6. China Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 7. Europe Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 8. Japan Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 11. India Immunological Agents Market Size (2017-2028) & (USD Million)
Figure 12. Immunological Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Immunological Agents by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Immunological Agents Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Immunological Agents Markets in 2021
Figure 17. United States VS China: Immunological Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Immunological Agents Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Immunological Agents Market Size Market Share by Type in 2021
Figure 20. Antirheumatic Drugs (DMARDs)
Figure 21. Immune Globulins
Figure 22. Immunomodulatory Agents
Figure 23. Immunosuppressive Agents
Figure 24. Monoclonal Antibodies
Figure 25. Other
Figure 26. World Immunological Agents Market Size Market Share by Type (2017-2028)
Figure 27. World Immunological Agents Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Immunological Agents Market Size Market Share by Application in 2021
Figure 29. Hospital
Figure 30. Clinics
Figure 31. Others
Figure 32. World Immunological Agents Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Immunological Agents in 2021
Figure 34. Manufacturing Process Analysis of Immunological Agents
Figure 35. Immunological Agents Industrial Chain
Figure 36. Distribution Channel Breakdown for Immunological Agents Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
